Gepimex 404 Company
FDA import alert and refusal historyCantho City, VietnamFEI 3002531111
As of October 26, 2026, Gepimex 404 Company (Cantho City, Vietnam) is on the red list of FDA Import Alert 16-81 (Seafood products: Salmonella) for all seafood products, published by FDA on September 18, 2009, and has no FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 16-81 · red list
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Gepimex 404 Company
1 record, newest first. Each line links to the FDA page it came from.
2009
- Import alert listingListed on Import Alert 16-81red listAll seafood productsSource
Questions about Gepimex 404 Company
- Is Gepimex 404 Company on an FDA import alert?
- Yes. As of October 26, 2026, Gepimex 404 Company is on the red list of FDA Import Alert 16-81, “Seafood products: Salmonella”, for all seafood products; FDA published the listing on September 18, 2009.
- Has FDA refused shipments from Gepimex 404 Company?
- No FDA import refusals for Gepimex 404 Company appear in FDA's refusal data since October 2016, as of October 26, 2026.
- What is Gepimex 404 Company's FEI number?
- Gepimex 404 Company's FDA Establishment Identifier (FEI) is 3002531111.
- Can shipments from Gepimex 404 Company still enter the U.S.?
- Shipments of all seafood products from Gepimex 404 Company can be detained without physical examination under Import Alert 16-81; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Gepimex 404 Company?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.